AstraZeneca Total Liabilities 2010-2024 | AZN

AstraZeneca total liabilities for the quarter ending June 30, 2024 were $64.742B, a 9.5% increase year-over-year.

  • AstraZeneca total liabilities for 2023 were $61.953B, a 4.25% increase from 2022.
  • AstraZeneca total liabilities for 2022 were $59.425B, a 10.07% decline from 2021.
  • AstraZeneca total liabilities for 2021 were $66.076B, a 29.33% increase from 2020.

AstraZeneca Total Liabilities 2010-2024 | AZN

  • AstraZeneca total liabilities for 2023 were $61.953B, a 4.25% increase from 2022.
  • AstraZeneca total liabilities for 2022 were $59.425B, a 10.07% decline from 2021.
  • AstraZeneca total liabilities for 2021 were $66.076B, a 29.33% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B